Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.

Improving Success in ART: How to define it and key strategies to get the best outcomes

Improving Success in ART: How to define it and key strategies to get the best outcomes
  • Reproductive medicine
  • Fertility
Regional conference by Excemed
Saturday, Dec 8 2018
Beijing, China

Event format

Learning Journey

Language

The  official  language  of  the  live  intervention  is  English. 

Registration status
Not applicable

To register for this event, contact

For registration, accommodation and any logistic inquiry please contact:

Meridiano Congress International

 

Congress Manager: Titty Alvino

T +39 06 88 595 310 - F +39 06 88 595 234

titty.alvino@meridiano.it

Registration fee

150.00€

The registration fee for the whole blended programme is EURO 150,00 and includes:


• Access to the online tutorials
• Scientific sessions
• Coffee breaks and luncheons
• Educational materials
• Certificate of attendance


Dinners are not included

Overview

Controlled ovarian stimulation (COS) now plays a major role in optimising IVF outcomes by facilitating control of different aspects of the process and increasing the number of oocytes available. COS aims to achieve maximal success with minimal side effects. Progress in and understanding of ovarian physiology, as well as new advances in ovarian stimulation strategies have made it possible for healthcare professionals to achieve the optimal outcomes for patients.

 

Success in assisted reproductive technology (ART) depends on carefully controlled conditions in every step of the laboratory routine. In addition, continuous advances in technology require constant revision of good laboratory practices and the introduction of new techniques. This educational activity will improve the participants’ knowledge of the latest technologies and laboratory practice guidelines.

 

The learning activity offers an interactive programme with specialised lectures tailored to fit the needs of physicians and embryologists working in ART, followed by lectures and case studies.

Learners will have the opportunity to discuss, directly with renowned scientists, pertinent topics that have been the subject of controversy and innovation.  Discussions will concentrate on how to facilitate optimal laboratory conditions, culture environments, selection criteria and how to select the best therapy for infertile patients

Learning objectives

By attending this live intervention, participants will be able to:

  • Define laboratory and clinical outcomes for defining success in ART
  • Key factors influencing the success of ART
  • Tailor the best stimulation protocol for patients undergoing ART
  • Discuss and debate changing approaches to ART

Accreditation details

The CME course “Improving success in ART: how to define it and key strategies to get the bt outcomes” held on 8 December 2018 in Beijing, China, is designated for a maximum of  6 (six)es hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME ® credits are recognized by the American  Medical  Association  (AMA) towards  the  Physician's  Recognition  Award  (PRA).  To convert EACCME ® credit to AMA PRA category 1 credit, please contact the AMA.

Scientific programme

Saturday, 8 December 2018

 

08.00                     Registration

09.00                     Introduction

                              R. Fischer, Germany

09.05                     Welcome opening

                              Q. Yu, China

               

Session I

Chair: R. Fischer, Germany

Panelists: Yuan Li, China – H. Y. Choi, South Korea

               

09.10     L1           What is success in ART? Slide kit

                              P.C. Wong, Singapore

09.35                     Question time

                              P.C. Wong, Singapore

                              

09.45     L2           The importance of oocyte numbers for cumulative live-birth rates Slide kit

                              S. K. Sunkara, UK

10.10                     Question time

                              S. K. Sunkara, UK

 

10.20                     Panel discussion

                              

10.55                     Coffee break

 

Chair: R. Fischer, Germany

Panelist: D. Zhang, China

 

11.15     L3           How to define subgroups for COS? Slide kit

                             C. nVeetis, Australia                              

11.40                    Question time

                             C. Venetis, Australia

 

11.50     L4           What kind and dose of gonadotropins to use in COS? Slide kit

                              C. Venetis, Australia

               

12.15                     Question time

                              C. Venetis, Australia

 

12.25                     Panel discussion

                                

13.00                     Lunch

Session II

Chair: R. Fischer, Germany

Panelists: Y. Xu, China – S. D. Kim, South Korea

                              

14.00     L5           From poor response to low prognosis: The POSEIDON concept Slide kit

                              R. Fischer, Germany

14.25                     Question time

                              R. Fischer, Germany

              

14.35     L6           The role of recent advancement in laboratory technology to improve ART outcome Slide kit

                              G. Coticchio, Italy

15.00                     Question time

                              G. Coticchio, Italy

 

15.10                     Panel discussion

 

15.40                     Coffee break

 

Chair: R. Fischer, Germany

Panelists: Y. Ma, China – J. H. Lee, South Korea

 

16.00     L7           The role of pre-implantation testing for aneuploidy to improve selection. What are the limits? Slide kit

                              G. Coticchio, Italy

16.25                     Question time

                              G. Coticchio, Italy

 

16.35     L8            Is the time ready for “freeze-all” strategy for all patients? What is the best frozen embryo transfer protocol? Slide kit

                              S. K. Sunkara, UK

17.00                     Question time

                              S. K. Sunkara, UK

 

17.10                     Panel discussion

 

17.40                     Concluding remarks

                              R. Fischer, Germany

                              Q. Yu, China

                              

17.45                     End of the workshop

 

CME provider

.

Chair(s)

Qi Yu

Peking Union Medical College Hospital
Beijing, China
Speakers

Christos Venetis

Women's and Children's Health Sydney
St George Hospital University of New South Wales
Sydney, Australia

Peng Cheang Wong

Yong Loo Lin School of Medicine
National University Health System Singapore
National University of Singapore
Singapore
Slide kit
Giovanni Coticchio
Reproductive medicine
Slide kit
Robert Fischer
Reproductive medicine
Slide kit
Sesh Kamal Sunkara
Reproductive medicine
Slide kit
Christos Venetis
Reproductive medicine
Slide kit
Christos Venetis
Reproductive medicine
Slide kit
Peng Cheang Wong
Reproductive medicine